-
Anti-neuronal antibodies can be detected in Sydenham's chorea, but not in PANDAS or Tourette's syndrome.
-
The King-Devick test, if validated in future studies, has the potential of becoming a standard sideline method for identifying athletes who have sustained a brain injury.
-
Frontal lobe dysfunction may presdispose people to have psychogenic nonepileptic seizures; this dysfunction can be measured by analyzing a brief period of the awake EEG.
-
Chronic fatigue syndrome, as defined by clinical symptoms, may improve with a combination of behavior thrapy and graded exercise.
-
Neurologists at the Mayo Clinic reviewed the morbidity and mortality of patients who underwent treatment for unruptured brain aneurysms,
-
-
Calcium supplements and MI; birth control pills and VTE; ACE inhibitors and breast cancer risk; spending on pharmaceuticals; and FDA actions.
-
A controlled surgical trial of glutamic acid decarboxylase gene therapy, targeting the subthalamic nucleus in advanced Parkinsons's disease, demonstrated statistically significant improvement in motor symptoms off medication in those receiving gene therapy compared with controls.
-
Carbamazepine has been linked with severe forms of hypersensitivity reactions. As such, genome wide approaches to identify patients-at-risk have become increasingly important.
-
A composite score that combines age, motor power, and light touch perception can predict recovery of walking with great accuracy in patients with traumatic spinal cord injury.
